… genital warts after primary carbon dioxide laser treatment before the introduction of the
vaccination against HPV. … recurrence rates of genital warts before HPV vaccination and underline …

… the burden of HPV, the risk factors for HPV infection, genital warts and cervical … genital wart
lesions found in over 8000 women who were participants in the placebo-arms of HPV vaccine …

… of the quadrivalent HPV vaccine prospective study, HPV DNA was detected in 90.8% of
genital wart biopsy samples; of these samples, 94.7% were positive for LRHPV-6 and/or HPV-11 …

… In this study, we describe the ongoing population effect of the quadrivalent human
papillomavirus vaccination programme on genital warts in Australian patients five years after the …

… of a nonavalent HPV vaccination for treatment of genital warts because the vaccine may
be beneficial as an alternative noninvasive treatment of recalcitrant genital warts. However, …

… cervical cancer plus genital warts, or … of the vaccine, the effect of information framing (’cervical
cancer’ versus ’cervical cancer plus genital warts’) on intention to receive the HPV vaccine …

… decreasing HPV infection and related diseases, such as warts … about current HPV vaccines,
focusing on vaccine coverage … genital warts caused by the HPV types covered by Gardasil [9,…

… -associated disease in vaccinated individuals. To derive the greatest public health benefit,
HPV vaccines offering protection from cervical cancer and genital warts will, ideally, be …

… of the national HPV vaccination program on private in-patient treatments for genital warts. …
the impact of the HPV vaccine program on in-patient treatment of genital warts in Australia. We …

… Prophylactic HPV vaccines have been developed based on recombinant L1 proteins that …
By 2014, HPV vaccination had been included in the national immunization programs of at least …